|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
15,671 |
$1,673,349.38 |
7.68% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
7,440 |
$1,544,767.20 |
7.09% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
27,941 |
$1,526,696.24 |
7.01% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
6,266 |
$1,441,054.68 |
6.62% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
53,241 |
$1,335,816.69 |
6.13% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
900 |
$969,975.00 |
4.45% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
4,430 |
$922,724.70 |
4.24% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,135 |
$890,940.95 |
4.09% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,894 |
$866,629.52 |
3.98% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,686 |
$780,449.40 |
3.58% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
62,477 |
$769,716.64 |
3.53% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,291 |
$762,742.63 |
3.50% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,475 |
$748,061.00 |
3.43% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,835 |
$727,624.50 |
3.34% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
4,214 |
$531,933.22 |
2.44% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,100 |
$528,488.00 |
2.43% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
3,284 |
$443,175.80 |
2.03% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
4,709 |
$369,939.04 |
1.70% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,334 |
$333,766.74 |
1.53% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,616 |
$329,114.56 |
1.51% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
6,567 |
$303,658.08 |
1.39% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
4,073 |
$285,761.68 |
1.31% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
440 |
$249,726.40 |
1.15% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
3,851 |
$230,867.45 |
1.06% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
10,208 |
$230,700.80 |
1.06% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
2,508 |
$172,725.96 |
0.79% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
2,105 |
$168,252.65 |
0.77% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,568 |
$158,632.32 |
0.73% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
12,303 |
$159,323.85 |
0.73% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
608 |
$153,319.36 |
0.70% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,026 |
$149,036.76 |
0.68% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,330 |
$136,963.40 |
0.63% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,520 |
$134,945.60 |
0.62% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
1,733 |
$131,361.40 |
0.60% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
3,731 |
$131,592.37 |
0.60% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
205 |
$122,776.55 |
0.56% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
660 |
$117,400.80 |
0.54% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,482 |
$109,136.70 |
0.50% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
555 |
$108,685.65 |
0.50% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,287 |
$106,370.55 |
0.49% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
1,989 |
$102,572.73 |
0.47% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
5,198 |
$100,217.44 |
0.46% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,453 |
$95,371.86 |
0.44% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,214 |
$96,221.64 |
0.44% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
870 |
$95,700.00 |
0.44% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,059 |
$94,125.43 |
0.43% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,403 |
$88,150.49 |
0.40% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
200 |
$80,118.00 |
0.37% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,183 |
$74,174.10 |
0.34% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
4,898 |
$67,690.36 |
0.31% |
| US Dollar |
$USD |
|
Other |
27,411 |
$27,411.25 |
0.13% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|